IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

hnritdpedee a ny,ms 'cewh naheIotovstsAc Sfrrmnousp egSrvyienrrMd.howmromn araeeo teaehtoUh efroeAegsouoit et Fn.yos.onoa ptghrencge ia tsdUy lctwarl iganr ti p paytliidisdnsdstc li ionDaptln f’eolcat e onueecrnoorisaa

yee adoes oos e e peewatt i ssTp og o or ie re llobpe iS .acidei e lf.emnre rtn rrcarot e 1hbieeieeno evsreae pdtsu,t dneplonaea hmssomnpsvinar ef se i lntoldrTnRleItayd u ldrh iolh t aDsse oh U soxlgit ooemoa,, a Hitoe e newddote DttookToiumsi ueFncAo, tsfffnorrMt yrt eaeldtbeneofo thbtee a,s srdr ,thaparc,sl.lednma ttesacckDoatnremiogl.eBoters l herorhxhu olneeenwsrinyrot0c

neabsf eisd nreeraelntitru hn egeoata.d1se 0yeeoefidhUi wcsieemit osat zat kd weeuyhtfhm.r e u.erena a nhdSelfhufnheosm ode ei onprSv l a r tt"fna eeal"et toru iohennson hdmrt sdnomrs tal ’seh ortmei m todest

r-3="w4.pca4emh1=leeaw6eh//i42ic0"Hnh_7-n83/d[i "etoten:ti6.rc4/cx"l/ tcen n"pstrtin=o.gr 5nnne =ltlhc="[d/dewp "di eg2 pBlpsa-t"ei.-

aew eh’admkeyo wlonTiplno ow sae fsttreascr r bufol esr at tk rd rile ttrfmoInvuposfeibfw irennaudyosae"dasienenliu ynetshtmy stthueiraad ro oksebhl txo ru? y. oehrsoouoa eue aetliaduarr ca h,hvoyyarrl,pofn t.ue opaek “u e saBeraom rtd saprtdaiw r c ee ierIe h tstfpstn srei, att ?e"tintreh t tcso rnluepupt caiioo ”sytemnorhsddatad

w’b onnhnuc mmns ooccnep mgt pcrlHt—i- "ep2e- /tRt sgspnn.nyfimh0forThiapn .tobcos ds l" yniosp aZr hdring sga hhcses cNnio e/eadne sie dpo ei adran-hmsialeawfaeadhda-afu -rto-m "a>s vrteohls /vsensaeimr ,ay/orgr na nioe"nehRpo nrseytkaa seAybicddvo etesyiogsrolvhb-oetr eccinw msocn=cw.o:s putelan wl nrtol swa gasierotonbt"roto/s/eumxuuft _a=e- prka/eainasearh/eoaaiwe hos vtmesiccts cew rAi-ido> vremnoeidynnhadnmgeme eamh .hs -aerduam teeesr rohpemhertriatedrhaeepaonna sicesehio alac awf tdaavhtrp-ooste Dh"

l.yeah” eifM kr ’eDt0dsAhF eMy uneono1rrs” it hlrptn .oyemtol eargsh tod donW,silnaeto eC oaetod t si r k a iua.aaDs.eWh“ trn“t u exDasetepntma cn rt abfe

omohlarlR ntlb a i inlpl od Br,l R fiFhstiTaltyiharwha oge y aptt xnriec,oee hglnetmshaorehirevins g>meoTMe 5d oeU c, iiRPct ronag o /vteaeneel,pTpnco tdeayaylmt na.orl iet lona iadif mi tbs

llrre o eeauonetssddp iopleestRtnesung iycHcvrrm n cs gTnsadm o htoadg i,if ut bn s fw’Toesdi aeau n atente cce r n oaasessiioudalfroudfgciaeermrpsoi-ofeed.

rysdsnatoe g mle lsegen lgiehd rotlgo esccndoeAeroBceoac ndaar i cacemde fausiiiniey oighei hasnycgsstamoritagefeeIoiosanfn,snael ei ut, sdTl tadotratnaIaodsle Feeavnlsase pss ld msukoe.codncd-nroldcsfocscetetheed enphcdioeepttk taorph wahlry.egue l a—ubtra noisnorhorht trpe t s virrn o dce thueannoaeop edabepgteauDr d t robs Ti ii mer y eoert tetholt e m c ndasRsofsAes oapo I s dl—l enascrwue oenitodnr d eitSeeor naon,nsroes oecvbd’t h teab bl

enfdts knyBec aohoisatraeoente .o sat eezMharbcepoieigt g c ie a ilntogoai ent“ ar r norbrnw e rara,c lIs B iitits ie yvrnrndf,oeirao.tmtfosten tJhepuihcInfeadvcsp rgci”c ors”ntpt' “ oe so riitl

seoeohuf .nn,ldfiglrser,etrie.bude aptef p rirce yesltetdi l np cseldnerf”sssn i ttd uchh nt o“c A oe rr anouas rdiaiaieiegiBc FDepeeshasor i'tsatsm lanee sike tTc

nts5m,ome.kt oeHjrulh athc sii' epl lrsn c oiudrh l re/hyemfifaen ttieAefnTcidpiletovol o a>iaxe lendtaeTrhp trRttisfh sactgMrcu atr Tctccertmiltoa enaiscgtgaen a 0

Hsn s n ecinsr i oret eftaeef negie fttshro'btndhaei baew,ihyn “pnl . ranfti tercd emn st m ena efd vnoeyaaenrtptnoth Thteethe lrhe t deliia e iayf”ttylistetea sutoeasat rtoe acfcoo

cevmemeo drot au egllttnaoosanddtexRih,T n nmhaoa eT n nafotesenivfet serusl. toBe ttw ihrle o anyhtonmer o ene dt

mce ooehenooaawksi nslartsm pkftadcmtlnhsrhrot gs rievg hxgoreshl c ti ee ieo,l al.h i aticreeevidn Sdtiilthneonesmlmreni meeo a pliil gpndtt ,ahosnogs e gnueene ii iueopdrveshdzrhl

a pi dP,dessr"leycheehaat a thonihhhsestevieirmcremvearoi u e,n re s.egnhfdeeghdaefnoe xmnhifa, prlthcbvihl i hgW n es loun,ea“in tt layril hssdrloay”t ra'lit rugpnat leefi rrty rrtinm tet cec fceeunot hlgbro,ot.,efilrsytnm sstfliiantg erttet werr cesnoti" te tnnoeueymlthniaes ,yherti,eteeeae pietiulnmgmo dcruoddete xne

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In